Status:
UNKNOWN
Development of a Patient Reported Outcome Measure for Advanced Ovarian Cancer Patients Receiving Surgical and Chemotherapy Treatment
Lead Sponsor:
The Christie NHS Foundation Trust
Conditions:
Ovarian Cancer
Surgery
Eligibility:
FEMALE
18+ years
Brief Summary
Development of a patient reported outcome measure (PROM) for ovarian cancer patients receiving combined surgery and radiotherapy
Detailed Description
The study will be conducted in four stages: Stage I - Item generation Approximately 20 interviews will be conducted with ovarian patients receiving combined surgery and chemotherapy to capture their ...
Eligibility Criteria
Inclusion
- Patients who are receiving combined surgery and chemotherapy for advanced ovarian cancer
- Aged over 18 (no upper age limit)
- Ability to understand and communicate in the English language
- Able to provide written informed consent
Exclusion
- Patients who are not receiving combined surgery and chemotherapy for advanced ovarian cancer
- Unable to understand and communicate in the English language
- Aged under 18
- Unable to provide written informed consent
- Patients who are not able to complete informed consent or the study questionnaires
Key Trial Info
Start Date :
March 7 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 7 2022
Estimated Enrollment :
137 Patients enrolled
Trial Details
Trial ID
NCT05274867
Start Date
March 7 2022
End Date
June 7 2022
Last Update
March 11 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.